Patients News | pharmaphorum

News

Lilly scores against Novo Nordisk in weight loss contest

There’s no data from a head-to-head trial directly comparing Eli Lilly and Novo Nordisk’s GLP-1 agonist drugs yet, but an observational study has found that Lilly’s tirzepatide seems to be

News

As IARC uprates talc cancer risk, will J&J be affected?

The International Agency for Research on Cancer (IARC) has published a new assessment of talc’s potential to cause cancer, concluding that is it ‘probably carcinogenic’ to humans.

News

New UK Prime Minister Keir Starmer (R), with Cabinet shoo-in Angela Rayner

NHS will take more than one term to fix, says Streeting

While the headlines are all about the Labour landslide in the UK general election this morning, Wes Streeting, who has been shadow health secretary in opposition and may well have the equiv

News

Survey reveals heavy burden of chronic hand eczema

People with chronic hand eczema (CHE) have reported the serious impact the condition can have on their daily lives in a UK survey.

News

Study links Ozempic/Wegovy to sight-threatening disorder

Shares in Novo Nordisk and Eli Lilly have been under pressure after a study emerged suggesting that people taking a GLP-1 agonist had an elevated risk of a rare but serious eye condition.

News

Purdue’s bankruptcy plan in tatters as SCOTUS says no

The Supreme Court of the US has rejected a bankruptcy deal that would settle opioid litigation against Purdue Pharma, but also protect the Sackler family that controls the company from liab

Lilly scores against Novo Nordisk in weight loss contest

As IARC uprates talc cancer risk, will J&J be affected?

NHS will take more than one term to fix, says Streeting

Survey reveals heavy burden of chronic hand eczema

Study links Ozempic/Wegovy to sight-threatening disorder

Purdue’s bankruptcy plan in tatters as SCOTUS says no

Lilly strikes again, buying CAR-T firm Orna for $2.4bn

How to meet your physicians where they are online

News

Editor's Picks